Patients with very advanced solid tumors saw no significant improvement in overall survival after receiving systemic therapy, according to a study published in JAMA Oncology by researchers at The University of Texas MD Anderson Cancer Center and Yale Cancer Center. The findings provide further evidence to help oncologists counsel patients that additional cancer-directed therapy is not likely to benefit them, allowing them to focus instead on palliative and supportive care options that have been demonstrated to improve quality of life and survival. “Our study highlights the importance of open and Read More
HEALTH DAILY NEWS
Health News, Medical News, Medical conditions, Medical Tests & Procedures, Symptoms, Medical Diagnosis , Health Information, FDA alerts, Drug Watch, Product Watch, Medicine Articles, Welfare, Living